NCT04312763View on ClinicalTrials.gov

A Validation of the Functional Low-Vision Observer Rated Assessment (FLORA-20) for Profoundly Blind Individuals

SuspendedOBSERVATIONAL
Enrollment

3

Participants

Timeline

Start Date

March 6, 2020

Primary Completion Date

December 8, 2024

Study Completion Date

February 20, 2025

Conditions
Blindness, Acquired
Trial Locations (1)

91342

Second Sight Medical Products, Inc., Sylmar

Sponsors
All Listed Sponsors
collaborator

Boston Biomedical Associates

OTHER

lead

Second Sight Medical Products

INDUSTRY

NCT04312763 - A Validation of the Functional Low-Vision Observer Rated Assessment (FLORA-20) for Profoundly Blind Individuals | Biotech Hunter | Biotech Hunter